Literature DB >> 27086928

Intestinal knockout of Nedd4 enhances growth of Apcmin tumors.

C Lu1, C Thoeni1, A Connor2, H Kawabe3, S Gallinger2, D Rotin1.   

Abstract

Nedd4 (Nedd4-1) is an E3 ubiquitin ligase that belongs to the HECT family and comprises a C2-WW(n)-HECT domain architecture. Although it has been reported to regulate growth factor receptors and cellular signaling, its role in cancer development has been controversial, with some studies proposing that it promotes cancer while others suggest it inhibits tumor growth. Here, we tested the effect of Nedd4 on intestinal tumor formation and growth using Nedd4-knockout mice (Nedd4 floxed (fl) mice crossed to villin-Cre mice). Although we find that knockout of Nedd4 on its own does not cause tumor growth, its knockout in the context of Apc+/min-derived colorectal tumors leads to augmentation of tumor growth, suggesting that Nedd4 normally suppresses intestinal WNT signaling and growth of colonic tumors. WNT signaling microarray, immunoblotting and immunohistochemistry analyses of tumors derived from the Villin-Cre;Nedd4fl/fl;Apc+/min colons demonstrated elevated expression of the WNT upstream effectors LEF1 (full length) and YY1 in these tumors relative to control (Apc+/min alone) tumors. Together, these results suggest that Nedd4 suppresses colonic WNT signaling and tumor growth, at least in part, by suppressing the transcription factors LEF1 and YY1.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27086928     DOI: 10.1038/onc.2016.125

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  55 in total

1.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain.

Authors:  Silke Wiesner; Abiodun A Ogunjimi; Hong-Rui Wang; Daniela Rotin; Frank Sicheri; Jeffrey L Wrana; Julie D Forman-Kay
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

3.  The C2 domain of the ubiquitin protein ligase Nedd4 mediates Ca2+-dependent plasma membrane localization.

Authors:  P J Plant; H Yeger; O Staub; P Howard; D Rotin
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

4.  Ubiquitin protein ligase Nedd4 binds to connexin43 by a phosphorylation-modulated process.

Authors:  Kerstin Leykauf; Mojibrahman Salek; Jörg Bomke; Matthias Frech; Wolf-Dieter Lehmann; Matthias Dürst; Angel Alonso
Journal:  J Cell Sci       Date:  2006-09-01       Impact factor: 5.285

5.  Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.

Authors:  E Porfiri; B Rubinfeld; I Albert; K Hovanes; M Waterman; P Polakis
Journal:  Oncogene       Date:  1997-12-04       Impact factor: 9.867

6.  Structural determinants for high-affinity binding in a Nedd4 WW3* domain-Comm PY motif complex.

Authors:  Voula Kanelis; M Christine Bruce; Nikolai R Skrynnikov; Daniela Rotin; Julie D Forman-Kay
Journal:  Structure       Date:  2006-03       Impact factor: 5.006

Review 7.  A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers.

Authors:  Olivia M Lucero; David W Dawson; Randall T Moon; Andy J Chien
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

8.  Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.

Authors:  Eric S Martin; Giovanni Tonon; Raktim Sinha; Yonghong Xiao; Bin Feng; Alec C Kimmelman; Alexei Protopopov; Elena Ivanova; Cameron Brennan; Kate Montgomery; Raju Kucherlapati; Gerald Bailey; Mark Redston; Lynda Chin; Ronald A DePinho
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

9.  Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas.

Authors:  Sung Soo Kim; Nam Jin Yoo; Eun Goo Jeong; Min Sung Kim; Sug Hyung Lee
Journal:  APMIS       Date:  2008-09       Impact factor: 3.205

10.  Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth.

Authors:  Hung-En Hsia; Rohit Kumar; Rossella Luca; Michiko Takeda; Julien Courchet; Jonathan Nakashima; Shumin Wu; Sandra Goebbels; Wenlin An; Britta J Eickholt; Franck Polleux; Daniela Rotin; Hong Wu; Moritz J Rossner; Claudia Bagni; Jeong-Seop Rhee; Nils Brose; Hiroshi Kawabe
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

View more
  10 in total

1.  NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.

Authors:  Shaoyan Feng; Guangwei Yang; Haidi Yang; Zibin Liang; Rongkai Zhang; Yunping Fan; Gehua Zhang
Journal:  Cell Cycle       Date:  2017-04-05       Impact factor: 4.534

2.  Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.

Authors:  Liping Lin; Xuan Wu; Yuanxue Jiang; Caijiu Deng; Xi Luo; Jianjun Han; Jiazhu Hu; Xiaolong Cao
Journal:  PeerJ       Date:  2022-05-24       Impact factor: 3.061

3.  NEDD4 regulates ubiquitination and stability of the cell adhesion molecule IGPR-1 via lysosomal pathway.

Authors:  Linzi Sun; Razie Amraei; Nader Rahimi
Journal:  J Biomed Sci       Date:  2021-05-07       Impact factor: 8.410

Review 4.  Circular RNAs Regulate Cancer Onset and Progression via Wnt/β-Catenin Signaling Pathway.

Authors:  Yun Feng Li; Jian Zhang; Lei Yu
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

5.  The NEDD4-1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma.

Authors:  Xi Huang; Huiyao Gu; Enfan Zhang; Qingxiao Chen; Wen Cao; Haimeng Yan; Jing Chen; Li Yang; Ning Lv; Jingsong He; Qing Yi; Zhen Cai
Journal:  Int J Cancer       Date:  2019-08-24       Impact factor: 7.396

6.  NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.

Authors:  Lingfeng Wan; Tao Liu; Zhipeng Hong; You Pan; Steven T Sizemore; Junran Zhang; Zhefu Ma
Journal:  Breast Cancer Res       Date:  2019-12-19       Impact factor: 6.466

7.  PINCH-1 promotes IGF-1 receptor expression and skin cancer progression through inhibition of the GRB10-NEDD4 complex.

Authors:  Xiaoxiao Wang; Rong Wang; Kun Jiang; Maohua Zhu; Ling Guo; Chuanyue Wu
Journal:  Theranostics       Date:  2022-02-28       Impact factor: 11.600

Review 8.  The many substrates and functions of NEDD4-1.

Authors:  Xi Huang; Jing Chen; Wen Cao; Li Yang; Qingxiao Chen; Jingsong He; Qing Yi; He Huang; Enfan Zhang; Zhen Cai
Journal:  Cell Death Dis       Date:  2019-12-02       Impact factor: 8.469

9.  NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor.

Authors:  Laura Novellasdemunt; Anna Kucharska; Cara Jamieson; Maria Prange-Barczynska; Anna Baulies; Pedro Antas; Jelte van der Vaart; Helmuth Gehart; Madelon M Maurice; Vivian Sw Li
Journal:  EMBO J       Date:  2019-12-23       Impact factor: 14.012

Review 10.  Ubiquitin Ligases Involved in the Regulation of Wnt, TGF-β, and Notch Signaling Pathways and Their Roles in Mouse Development and Homeostasis.

Authors:  Nikol Baloghova; Tomas Lidak; Lukas Cermak
Journal:  Genes (Basel)       Date:  2019-10-16       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.